Which client is at greatest risk for respiratory depression when receiving opioids for pain control?

Which client is at greatest risk for respiratory depression when receiving opioids for pain control?

• A. 20-year-old client with bronchitis receiving inhaled bronchodilator therapy
• B. 30-year-old client with heroin addiction and rotator cuff repair surgery
• C. 50-year-old client with sleep apnea and cellulitis scheduled for a bone scan
• D. 70-year-old client with chronic obstructive pulmonary disease and knee replacement

Answer: (D)

The client who is 70 years old with chronic obstructive pulmonary disease (COPD) and is scheduled for knee replacement surgery is at the greatest risk for respiratory depression when receiving opioids for pain control. This risk is primarily due to the nature of COPD, which already compromises the lungs' ability to function effectively. In patients with COPD, the respiratory drive may be diminished, particularly when opioids are administered, as these medications can depress the central nervous system and respiratory function. This can exacerbate the underlying respiratory issues that COPD patients face, leading to increased potential for hypoventilation and respiratory failure. Additionally, older adults often have physiological changes that affect drug metabolism and excretion, as well as the potential for increased sensitivity to opioids. This combination of factors makes the older patient with COPD particularly vulnerable to the side effects associated with opioid use, including respiratory depression. Monitoring and careful dosing are essential in this population to mitigate these risks when managing pain postoperatively.

The client who is 70 years old with chronic obstructive pulmonary disease (COPD) and is scheduled for knee replacement surgery is at the greatest risk for respiratory depression when receiving opioids for pain control. This risk is primarily due to the nature of COPD, which already compromises the lungs' ability to function effectively.

In patients with COPD, the respiratory drive may be diminished, particularly when opioids are administered, as these medications can depress the central nervous system and respiratory function. This can exacerbate the underlying respiratory issues that COPD patients face, leading to increased potential for hypoventilation and respiratory failure.

Additionally, older adults often have physiological changes that affect drug metabolism and excretion, as well as the potential for increased sensitivity to opioids. This combination of factors makes the older patient with COPD particularly vulnerable to the side effects associated with opioid use, including respiratory depression. Monitoring and careful dosing are essential in this population to mitigate these risks when managing pain postoperatively.